Short-Term Improvement in
QoL With Infliximab Measured by IBDQ

Improvement per IBDQ Question From Baseline to 4 Weeks

0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

1.8

Total

Bowel

Social

Emotional

Systemic

p<0.001

p<0.001

p<0.001

p=0.002

p=0.007

Placebo
Infliximab

Change per Question

Lichtenstein GR et al. Inflamm Bowel Dis. 2002;8:237.